Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody molecules to PD-L1 and methods of treating cancer

Antibody molecules to PD-L1 and methods of treating cancer

US Patent 10851165 · Granted Dec 1, 2020

Estimated economic value: $41,189,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-specific antibody constructs2025
Multi-specific antibody constructs2025
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconj2025
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconj2025
Chimeric antigen receptors and uses thereof2025
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereo2025
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereo2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Antibody molecules to LAG-3 and uses thereof2025
Antibody molecules to LAG-3 and uses thereof2025
Antibody molecules to LAG-3 and uses thereof2025